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In recent years, the development of antibiotic resistant bacteria has become a global concern which has prompted
research into the development of alternative disease control strategies for the swine industry. Bacteriophages (viruses
that infect bacteria) offer the prospect of a sustainable alternative approach against bacterial pathogens with
the flexibility of being applied therapeutically or for biological control purposes. This paper reviews the use of
phages as an antimicrobial strategy for controlling critical pathogens including Salmonella and Escherichia coli
with an emphasis on the application of phages for improving performance and nutrient digestibility in swine
operations as well as in controlling zoonotic human diseases by reducing the bacterial load spread from pork
products to humans through the meat.
Keywords: Antibiotic resistance, Bacteriophage, Food safety, Phage therapy, SwineBackground
In the past two decades, bacterial diseases caused by
pathogens such as Escherichia coli and Salmonella
have become a major issue for the swine industry [1].
Antibiotics commonly used worldwide represent a
relatively efficient way to eliminate infectious patho-
gens [2]. However, recent studies indicate that the
abuse of antibiotics has led to several negative effects
such as antibiotic residues in meat products and the
development of antibiotic resistant bacteria [3, 4].
With many countries banning the use of antibiotics to
control bacterial infections in swine, studies on alterna-
tives with antimicrobial effects have become increasingly
popular [3, 4]. Among the various alternatives available
(i.e. probiotics, prebiotics, oligosaccharides, antimicro-
bial peptides and essential oils), phages are starting to
receive increased attention due to their special charac-
teristics, such as widespread distribution, self-replication
and a lack of effects on the normal microflora of treated
animals [5]. In this paper, we review the results and
findings of recent studies regarding the application of
phages in swine production including a discussion of* Correspondence: bioypxu@hotmail.com
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What are bacteriophages?
Bacteriophages are viruses that affect bacteria. Phages
are very common in all natural environments and play
an important role in bacterial evolution [6]. Virulent
phages can be isolated from sources such as swine feces,
waste water and soil indicating that they are fairly
widespread in commercial swine facilities and therefore,
it should be easy to obtain phages specific for many of
the diseases present in most swine operations [7]. In our
previous study, Niu et al. [8] recovered phages in 239 of
855 samples (26.5 % of 411 pooled fecal pats, 23.8 % of
320 fecal grab samples, 21.8 % of 87 water trough
samples, and 94.6 % of 37 pen floor slurry samples).
Studies in feedlot calves indicate that environmental
factors such as moisture level and temperature influ-
enced the presence of E. coli O157:H7 phage [9].
Phages can be categorized into two types, namely
virulent (exclusively undergo the lytic cycle) and tem-
perate (are able to endure the lysogenic cycle) [10].
Phages are very specific as each type generally attacks
different bacterial species. Virulent phages enter the
bacterial cell, replicate using the host machinery and
finally lyse the host cell, leading to the disintegration
of the bacteria. In contrast, temperate phages enter
the cell and instead of creating new phage particles, the
phage DNA first integrates into the bacterial chromosomeis distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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each time the host cell divides. Eventually a stimulus such
as ionizing radiation or a specific chemical induces the
prophage to initiate the lytic cycle. Temperate phages
can’t be used as antimicrobial agents for therapeutic
purposes, as they may transfer genetic material from one
bacterial cell to another. This may result in unpredictable
horizontal gene transference such as toxic or antibiotic
resistance genes which may cause detrimental effects on
therapy. In contrast, virulent phages rapidly exterminate
the bacteria, enabling them to be used as efficient antibac-
terial agents [11].
Use of phages in the swine industry
Although phage therapy has been used successfully in
swine since the early 1920’s [12], it has only recently started
to attract the attention of the research community as a tool
for use against bacterial diseases in swine. These endeavors
have resulted in a renewed interest in phages as a means of
preventing and treating bacterial diseases in swine opera-
tions [4]. The objectives of using phage therapy in the swine
industry include reducing the impact of infectious diseases
caused by several bacterial pathogens on animal health and
production as well as controlling zoonotic human patho-
gens by reducing the bacterial load spread from swine to
humans through pork [13]. Moreover, there is increased
interest in the use of phages for post-harvest control of bac-
terial microorganisms in both pork products and processed
foods [14].
Use of phages to improve pig performance and
nutrient digestibility
Three investigations about the effects of phage therapy
on pig performance are summarized in Table 1. Yan et al.Table 1 Effects of dietary supplementation with phages on pig perf
Diets ADG, g ADFI, g G:F R
BD1 459 1284 0.36 Y
BD + 22 ppm tylosin 464 1231 0.38
BD + 0.025 % phage 455 1294 0.35
BD + 0.05 % phage 472 1272 0.37
BD 737 2079 0.35 K
BD + 0.5 g/kg phage 764 2129 0.36
BD + 1.0 g/kg phage 815 2240 0.36
BD + 1.5 g/kg phage 822 2222 0.37
Before challenge4 CON2 654 1688 0.39 G
AST3 627 1652 0.38
After challenge CON 273a 1,313a 0.21a
AST 719b 1,938b 0.08b
1BD = Basal diet. 2CON = control diet with no added antimicrobial
3AST = 3 × 109 PFU/kg anti-Salmonella typhimurium phage supplementation
4Values are calculated for the 2 weeks before Salmonella typhimurium challenge an
a,bMeans in the same column with different superscripts differ (P < 0.05)[15] reported that dietary supplementation with anti-
Salmonella phage had no effect on average daily gain
(ADG) or gain:feed (G:F) of growing pigs. However,
Kim et al. [16] reported an improved ADG and aver-
age daily feed intake (ADFI) with increasing dietary
phage supplementation but there was no effect on
G:F. Gebru et al. [17] observed an improvement in
ADG and a decrease in G:F in Salmonella challenged
pigs fed diets supplemented with 3 × 109 PFU/kg anti-
Salmonella typhimurium phage. The difference in results
is believed to be associated with differences in the level
and type of phage investigated, health status within herds,
farm hygiene, diet composition, feed form and interactions
with other dietary feed additives.
Results obtained in nutrient digestibility experi-
ments indicate that pigs fed diets supplemented with
phage have greater nutrient digestibility (Table 2). Yan
et al. [15] reported an improved dry matter, nitrogen
and energy digestibility for growing pigs fed diets
supplemented with 0.025 and 0.05 % anti-Salmonella
phage. In agreement with Yan’s work, Kim et al. [16]
reported a small increase in dry matter and energy
digestibility with increasing concentrations of phage
from 0.5 to 1.5 g/kg.
It is well known that the microflora in the gastrointes-
tinal tract play a number of important roles in swine pro-
duction because the intestine is an important nutrient
absorption site. Therefore, a possible reason for the in-
creased digestibility observed in phage treated pigs is likely
to be their improved bacterial profile in the gut. Reduced
populations of Salmonella and coliform and increased
numbers of Lactobacillus and Bifidobacterium, which
have been observed in fecal microflora investigations in
pigs fed diets supplemented with phage [16], are inormance
eference Aims
an et al. [15] Evaluate the effects of Salmonella phages on the
performance of growing pigs
im et al. [16] Effects of dietary supplementation with phages,
probiotics and a combination of the two on pig
performance
ebru et al. [17] Effects of dietary supplementation with probiotic,
anti- Salmonella typhimurium phage, organic acid
combinations, or fermented soybean on pig
performance
d the 2 weeks after challenge
Table 2 Effects of phages on nutrient digestibility in pigs
Diets Dry matter Nitrogen Energy Crude protein References
BD1 0.774b 0.770b 0.766b Yan et al. [15]
BD + 22 ppm tylosin 0.801a 0.784ab 0.792a
BD + 0.025 % phage 0.793a 0.801a 0.778ab
BD + 0.05 % phage 0.796a 0.792a 0.785ab
BD 0.841 0.874 0.831 Kim et al.[16]
BD + 0.5 g/kg phage 0.846 0.875 0832
BD + 1.0 g/kg phage 0.847 0.875 0.838
BD + 1.5 g/kg phage 0.852 0.879 0.845
1BD = Basal diet
a,bMeans in the same column with different superscripts differ (P < 0.05)
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with anti-Salmonella phage [17].
Table 3 shows the anti-Salmonella and anti-coliform
activity resulting from increased levels of phage sup-
plementation. The increased numbers of Lactobacillus
and Bifidobacterium are believed to make a large con-
tribution to the improvement in pig performance and
nutrient digestibility observed in other experiments.
Wall et al. [18] reported that administration of anti-
Salmonella phage to pigs challenged with Salmonella
could reduce Salmonella colonization in the ileum
and cecum by 90 to 99.9 %.
Therapeutic uses of phages
Salmonella infections
Salmonella, which is responsible for severe diarrhea in
humans, is considered as one of the most common food
and water-borne pathogens in the world and a variety of
serum types have been separated from the different
stages of the pig production process [19]. It is a fact that
the increasing incidence of Salmonella being isolated
from healthy finishing swine threatens food safety and
limits meat export opportunities from pork-producing
countries [20].
Human Salmonellosis is typically associated with cross-
contamination and temperature/time abuse of meatTable 3 Effects of phages on fecal microflora numbers (log10 CFU/g
Diets Lactobacillus Bifidobacterium
BD1 6.89b
BD + 22 ppm tylosin 6.93b
BD + 0.025 % phage 7.16ab
BD + 0.05 % phage 7.52a
BD 8.56 8.92
BD + 0.5 g/kg phage 8.67 9.37
BD + 1.0 g/kg phage 9.06 9.77
BD + 1.5 g/kg phage 8.98 9.75
1BD = Basal diet
a,bMeans in the same column with different superscripts differ (P < 0.05)products in which Salmonella can reach numbers suf-
ficient to cause infections in the human body [21].
Owing to increasing reports of antimicrobial resistance in
Salmonella, the importance of controlling this pathogen
by finding alternatives to the use of antibiotics to reduce
Salmonella in swine should be stressed [20].
Different types of Salmonella phages have been isolated
from effluent lagoons, sewage and feces of swine [22]. A
high abundance of Salmonella phage was observed in
swine effluent lagoons, including one study which re-
ported levels as high as 2.1 × 109 PFU/mL [22]. In
addition, phages active against Salmonella typhimurium
were isolated from 1 % of the individual fecal samples
which showed that phage populations might vary in ac-
cordance with Salmonella populations [19].
To date, at least 25 Salmonella phage genomes have
been reported, in which the genome size ranged from 33
to 240 kb [14]. This indicates that a variety of Salmonella
phages exist in nature. The presence and diversity of
phages in a variety of environments indicates that specific
phages with high virulence could be easily obtained which
may help the development of Salmonella pathogen reduc-
tion strategies in the swine industry.
Several virulent phages have been used to reduce
the concentration of various species of Salmonella,
including Enteritidis and Typhimurium [23, 24]. Most) in pigs
Coliforms Salmonella References
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typhimuriumγ4232 in artificially-infected market-weight
swine and S. typhimuriumγ4232 was reduced by 2–3 log10
CFU [25]. Several reports suggest that treatment with
a large number of phages is desirable and there was
no evidence to suggest that the highest possible con-
centrations of phages should not be used [26].
Albino et al. [27] isolated a Salmonella phage belonging
to the Podoviridae family, which significantly reduced
(P < 0.05) Salmonella at a relatively low concentration
(107 PFU/mL) in an in vitro experiment. However,
the in vivo results were not statistically significant in
any of the analyzed intestinal locations (ileum, cecum,
feces), although Salmonella was detected in the feces
of challenged animals after treatment with phages at
a concentration of 107 PFU/mL. The reason for the low
activity of phage in vivo may be due to an inappropriate
micro-ecology in the animal’s gut. In another study, a sig-
nificant reduction of Salmonella typhimurium concentra-
tion in several tissues was observed by Lee and Harries
[28] in an experiment in which piglets were fed a single
broad-spectrum virulent phage.
E. coli O157:H7 infections
Since E. coli O157:H7 was identified in 1983 [29], it has
been recognized as an important zoonotic human patho-
gen. Previous outbreaks of E. coli O157:H7 infection re-
sulted from food, water and direct fecal contact [30].
Infection with E. coli O157:H7 resulted in diarrhea,
hemorrhageic colitis, hemolytic-uremic syndrome and
thrombotic thrombocytopenic purpura [31]. Moreover,
E. coli O157:H7 have been associated with numerous
diseases such as bloody diarrhea and hemolytic uremic
syndrome in humans [32]. Previous studies on phages,
primarily used to control pathogenic E. coli in pigs,
calves and lambs [33] achieved very promising results.
A relatively abundant E. coli O157:H7 phage was iso-
lated from swine feces in a recent study [34]. Morita et al.
[32] investigated a swine stool sample which contained
4.2 × 107 PFU/g of the E. coli O157:H7 specific phage
PP01, indicating that phage PP01 might suppress its host
E. coli O157:H7 in the gastrointestinal ecosystem.
Several studies have evaluated the antimicrobial ability
of phages targeted against E. coli. Smith and Huggins
[33] investigated the efficacy of a two-phage mixture
against infection induced by the ETEC strain P433 in
neonatal pigs. In an in vitro experiment, both phages
showed a high capacity to lyse bacteria with nine parti-
cles of P433/1 and four particles of P433/2 required to
completely lyse broth cultures of their respective hosts.
In addition, the results of this work indicated that
phages that targeted colonizing pili (F4, F5, F6 or F18)
were more effective in controlling a larger proportion of
the porcine ETEC than phages that target other pili [33].A study using anti-ETEC phage therapy in swine was
conducted by Jamalludeen et al. [11]. Six phages lysing
the ETEC strain O149:H10:F4 and three phages lysing
the ETEC strain O149:H43:F4 were isolated with 10
strains of ETEC used in total. For 85 strains of
O149:H10 ETEC, Phage GJ1-GJ6 lysed 99–100 % of
them, while for 42 strains of O149:H43 ETEC, only 0–
12 % strains were lysed by phage GJ1-GJ6. Three other
phages (GJ7-GJ9) selected against an O149:H43 host
strain lysed 86–98 % of 42 strains of O149:H43 and 2–
53 % of strains of O149:H10 [11]. Subsequently, phages
GJ1-GJ7 were individually evaluated for their ability to
treat an experimental infection with an O149:H10:F4 en-
terotoxigenic E. coli in weaned pigs. A significant reduc-
tion in the severity of diarrhea and the composite
diarrhea score was observed in a prophylactic treatment
supplemented with a combination of three phages,
which indicates that the selected phage cocktail was ef-
fective in controlling the experimental ETEC strain
O149:H10:F4 [11].
Similar to the application of phage in pigs, Waddell
et al. [35] showed successful elimination of E. coli
O157:H7 in experimentally inoculated (109 CFU) calves
through the oral administration of 1011 PFU of a mix-
ture of six phages on days −7, −6, −1, 0 and 1 post-
inoculation with pathogenic E. coli O157:H7. The results
obtained with pigs and calves reinforce the idea that
treatments with multiple doses and different administra-
tion times are important in effective phage therapy,
which will make significant differences to the effective-
ness of phages.
Use of phages to increase food safety
One important source of food contamination by E. coli
O157:H7 is the transmission of the bacterium from feces
onto meat during slaughter [36]. O’Flynn et al. [37] eval-
uated whether a phage cocktail could be used to remove
or decrease bacteria on meat carcasses. A phage cocktail
which consisted of phages e11/2, e4/1c, and pp01 was
pipetted medially onto nine slices of meat contaminated
with a rifampin-resistant derivative of E. coli O157:H7
strain P1432. Among those samples that were treated
with phage cocktails, seven of the nine samples were
completely free of E. coli O157:H7, which was deter-
mined by a viable plate count after enrichment. How-
ever, control pieces of meat were positive, exhibiting
counts of E. coli O157:H7 of 105 CFU/mL [37]. Al-
though this research was conducted with cattle, it indi-
cates that the surface application of phages is a feasible
approach for food preservation and could also be applied
to pork.
A phage cocktail (PC1), able to lyse a variety of S.
enterica, was modified to use the broad host-range
phage Felix O1 and three phages isolated from sewage.
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artificially-contaminated with multi-drug resistant S.
typhimurium U288, produced a significant (P < 0.05)
decrease in S. typhimurium U288 (Table 4) [14]. The
use of a MOI in excess of the bacterial concentration
seems to be closely related to the effectiveness of the
treatment. Bacterial counts were at undetectable levels
after the application of PC1 to pig skin (>99 % reduction).
In this research, the low temperature (4 °C) required for
meat storage did not decrease the passive action of
the phage. This result indicates that the contamina-
ting Salmonella could be eliminated by phage before
potential exposure of consumers to meat products.
Problems associated with the use of phages
Although phage therapy has many advantages, previous
research suggests that the use of phages exhibit some
disadvantages [11, 38]. Firstly, phages have a narrow
range of hosts resulting in a limitation of their use for
broad-spectrum protection [11]. In addition, it is pos-
sible to have an immune response to the administered
phages in the animal body [39]. Finally, bacteria resist-
ance to the virulent phage can be caused by phage and
bacteria co-evolution [39]. However, due to rapid devel-
opments in the field of phage therapy, it is hoped that all
limitations which currently exist will soon be resolved.
According to the results shown in previous work,
phages are unstable in the stomach and upper small in-
testine. The results [9, 33] obtained with the applica-
tion of orally administered phages in infected animals
including piglets suggest phages are sensitive when
exposed to a low pH (~pH 2), but showed considerable
stability at a high pH. Additional research should focus onTable 4 Mean log10 CFU counts of Salmonella typhimurium
U288 recovered from experimentally-contaminated 4 cm2 pig skin
sections of control and bacteriophage cocktail PC1 treated samples
U288 inoculum, CFU Phage inoculum, PFU Untreated
controlsSample time 107 105 104
1 h
106 6.2 ± 0.1 6.1 ± 0.2 6.2 ± 0.2 6.2 ± 0.1
104 3.5 ± 0.1* 3.7 ± 0.2* 4.6 ± 0.1 4.7 ± 0.2
103 3.8 ± 0.1 3.3 ± 0.4 3.4 ± 0.1* 4.2 ± 0.2
48 h
106 5.0 ± 0.1* 5.9 ± 0.2 6.5 ± 0.2 6.3 ± 0.1
104 2.9 ± 0.4* 3.9 ± 0.1* 4.1 ± 0.1 4.3 ± 0.1
103 3.6 ± 0.2 3.6 ± 0.4 ND 4.1 ± 0.2
96 h
106 5.5 ± 0.2* 6.6 ± 0.2 6.7 ± 0.1 6.5 ± 0.2
104 3.2 ± 0.3* 3.4 ± 0.2* 4.1 ± 0.4 4.5 ± 0.1
103 2.8 ± 0.7 ND ND 4.3 ± 0.3
Hooton et al. [14]. ND = not detectable; *P < 0.01 compared with control valuesthe need for protective strategies within the gastrointes-
tinal tract for the administration of phages, such as micro-
encapsulation to allow the phages to adapt to a wider pH
range [40, 41].
Ma et al. [40] evaluated the development of a mi-
croencapsulated phage Felix O1 for oral delivery using
a novel chitosan-alginate-CaCl2 system. In this study,
the viability of free and encapsulated phages when
they were subjected to simulated gastric fluid and bile
salts was compared. A large proportion of phage Felix
O1 micropheres retained their biological activity in a
simulated gastrointestinal tract environment which in-
dicates that the encapsulation technique may help the
phages survive at a low pH in the stomach and then
subsequently act in the small intestine. In addition,
Brussow [42] suggested that administration of phages
immediately after feeding was a promising strategy in
order to avoid exposure to a low pH in the stomach.
However, a low pH will not cause a serious problem
in young animals because they have a higher pH in
their stomach [26].
Phage sensitivity to temperature is another important
factor which could affect the effectiveness of phages in
animals. A previous study [43] reported that the in vitro
virulence of most phages tested declined drastically at
24 °C, and sometimes at 20 °C, suggesting that environ-
mental temperature could be a limiting factor in deter-
mining the ability of phages to multiply outside the
animal body. In fact, Smith et al. [43] reported that the
virulence of some temperature sensitive phages was
reduced around 37 °C, which is the normal body
temperature for most animal species including pigs.
They suggested that selection of phage mutants that
were not so sensitive to temperature could be of value
in overcoming the negative effects of temperature on the
effectiveness of phage therapy. Moreover, utilization of
microencapsulated phages showed an optimistic result
to prevent the degradation of phage particles from high
temperatures in a previous in vivo study [9, 33].
Another factor that may attenuate phage activity is the
rapid development of phage-resistance. Phage resistance
might result in three ways including the blocking of
phage receptors, the production of an extracellular
matrix and the production of competitive inhibitors. In
addition, other mechanisms such as preventing phage
DNA entry, cutting phage nucleic acids and abortive
infection systems play an important role in phage-
resistance as well [6]. Compared with the antibiotic-
resistance developed by pathogens, phage therapy seems
to face similar problems as the rapid development of
phage resistance could reduce their infective efficiency.
However, diversity of phage types and the likelihood of
quick phage isolation increases the feasibility of new
phage cocktail development. The use of cocktails
Zhang et al. Journal of Animal Science and Biotechnology  (2015) 6:39 Page 6 of 7consisting of various phages with the use of different
bacterial receptors has been proposed to circumvent re-
sistance problems [44].
Conclusions
Phage therapy shows significant potential to be used as a
viable strategy to restrain and cure infectious diseases
caused by major pathogens in the swine industry. A num-
ber of commercially produced phage products have been
approved to be used as bio-control agents in the field of
poultry raising, cattle breeding, and food preservation
[45–48]. However, the use of phages is still limited in con-
trolling food borne pathogens in live animals as well as in
understanding the mechanism through which they im-
prove pig performance. Without an understanding of the
essential problems including phage resistance, phage-host
interactions, the microbial ecosystem, and the host animal,
this biological pathogen control system will not be used to
its fullest potential in improving swine production.
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